Best in Biotech 18 Mar 2025 Cancer vaccines: 11 biotechs to keep an eye out for As various biotechs across the world specialize in the production of cancer vaccines, here are 11 companies making progress in the field. March 18, 2025 - 14 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 12 Feb 2025 Dendritic cell therapy: Diakonos, Northwest Biotherapeutics and Mendus push ahead with next-generation candidates Find out about the field of dendritic cell therapy, as several companies attempt to bring next-generation candidates through the clinic. February 12, 2025 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 5 Feb 2025 Needle-free vaccines: Micron Biomedical, Vaxxas, and IntegriMedical bring their new technologies to patients Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in this space. February 5, 2025 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 17 Dec 2024 Ovarian cancer: BioNTech, Curelab, OvarianVax and more bring vaccines to the clinic A number of ovarian cancer vaccines are being evaluated including the world’s first cancer prevention vaccine, which recently received funding. December 17, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 2 Dec 2024 The rise of cancer vaccines: A new era in immunotherapy Delve into the expanding and diverse field of cancer vaccines with various approaches exploiting the immune system to fight tumors. December 2, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 29 Nov 2024 Trump’s healthcare picks: Who they are and what they mean for the biopharma industry Trump’s nominees for top healthcare roles have sparked significant debate. So, what do their appointments signal for the future of healthcare in the U.S.? November 29, 2024 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 6 Nov 2024 Tuberculosis research: Are we finally close to developing a more effective treatment option? Learn more about the positive advancements that have been made in tuberculosis research in an attempt to find new treatment options. November 6, 2024 - 12 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 30 Sep 2024 The race for a bird flu vaccine: milestones and breakthroughs The recent uptick in U.S. bird flu cases poses a threat to public health. Biotechs are now developing vaccines to mitigate the outbreak. September 30, 2024 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 23 Sep 2024 Vicebio and its molecular clamp vaccine raise big to tackle respiratory viruses Discover Vicebio’s molecular clamp technology as it completes a $100 million series B round for its bivalent vaccine against RSV and hMPV. September 23, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 30 Aug 2024The future of combination vaccines To look at combination vaccines, listen to our conversation with Cesar Sanz Rodriguez, vice president, Europe & Switzerland, medical affairs, at Moderna. August 30, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
In Depth 9 Aug 2024 The therapeutic potential of circular RNA: Could it soon trump mRNA technology? Find out about circular RNA, an emerging technology that could hold a lot of promise for next-generation vaccines and gene therapies. August 9, 2024 - 5 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 29 Jul 2024 Influenza solution deals pile up as pandemic preparedness increases Influenza deals have been piling up in the last few weeks. Discover why that is and how are companies and government preparing for pandemics. July 29, 2024 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email